Page 53 - Read Online
P. 53

Liu et al. Hepatoma Res 2020;6:7  I  http://dx.doi.org/10.20517/2394-5079.2019.39                                                    Page 7 of 16

                 Increased size and multiplicity in HFHC- fed mice compared with HFD-fed mice WG, IR, steatosis and inflammation   present Median diameter of tumours = 9 mm WG, IR, steatosis, inflammation and   fibrosis present Weight loss, steatosis, inflammation   and fibrosis present  WG, diabetes (no IR), steatosis,  inflammation and fibrosis present  Insulin hypersensitivity, steatosis and  inflammation but no fibrosis present Other examples of single gene knockout

















                 At 8 months, tumours displayed in:     HFD 90%     HFHC 100%  30% displayed tumours at 6 months 100% displayed tumours at 9 months  83% displayed tumours at 24 weeks   100% displayed tumours at 20 weeks.  No female mice developed tumours  At 74-78 weeks, tumours displayed in:     Males 66%     Females 30%  100% displayed tumours at 9 months  78.6% displayed had tumours > 2 mm,  and 35.7% displayed tumours > 10 mm  fibrosis present  at 40 weeks 4/13 (30.7%













                 DEN 25 mg/kg i.p. single dose at Week   CCl 4  0.2 µL/g i.p. weekly from Weeks   DEN 25 mg/kg i.p. single dose at Day 14 TAA 300 mg/L in drinking water from   Week 4  DEN 25 mg/kg i.p. single dose at Week   DEN 25 mg/kg i.p. single dose at Day 15 *List of models presented are not intended to be exhaustive but to give representative examples of different combinations of methods to achieve hepatocarcinogenesis in alcoholic and metabolic liver  diseases. AFP

















                 HFD or HFHC   3 from 6 weeks  CDAA from   6-8  Weeks 6-8  HFD from Week 4  HFD from Week 4  STZ 200 µg s.c. at Day 2  -  -  -   2  HFD from Week 6  -  - Added 10 mg   ferrous sulphate/  kg normal chow   from 8-15 months   for 6-8 months  -





                                            Hepatocyte-  specific PTEN   knockout:  AlbCrePten flox/  deficient   genetically   obese (Ob)  MUP-uPA   transgene  microglobulin   knockout  Hepatocyte   specific FBXL5   knockout: Alb-  Cre/Fbxl5 flox/  flox  mice stelic animal model; STZ: streptozotocin; TAA: thioacetamide; WD: Western diet; WG: weight gain



                 -      -     -     -             flox  Leptin         β2-
                 C57BL/6J   male  C57BL/6J   male  C57BL/6J   male  C57BL/6   male and   female  C57BL/6J   male and   female  C57BL/6J   male  C57BL/6   male  C57BL/6   male and   female  C57BL/6   male and   female








                 HFHC + DEN   Liang et al. [63]    CDAA + CCl 4 De Minicis et al.  [56]    HFD + DEN + CCl 4 Henderson et al. [64]    STAM  Fujii et al. [66]    PTEN knockout  Horie et al. [28]    Leptin deficiency (Ob) +   DEN  Park et al. [62]    MUP-uPA  Nakagawa et al. [71]    Haemochromatosis HCC models  β2-microglobulin   knockout  Rothenberg et al. [76]    FBXL5 knockout   Muto et al. [77]
   48   49   50   51   52   53   54   55   56   57   58